Evidence map›Paper›PMID 9400713›Full record

ArticleEnvironmental health perspectives1997

Asbestos and silica-induced changes in human alveolar macrophage phenotype.

A Holian, M O Uthman, T Goltsova, S D Brown, R F Hamilton

Open access · diamondAbstract read
In one paragraph

Article in Environmental health perspectives, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 53 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. The Secretory Response of Rat Peritoneal Mast Cells on Exposure to Mineral Fibers.International journal of environmental research and public health · 2018
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Autoimmunity and asbestos exposure.Autoimmune diseases · 2014
    Review
  12. Article
  13. Nonpulmonary outcomes of asbestos exposure.Journal of toxicology and environmental health. Part B, Critical reviews · 2011
    Review
  14. Article
  15. Silica binding and toxicity in alveolar macrophages.Free radical biology & medicine · 2008
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

A HolianDepartment of Internal Medicine, University of Texas Houston Health Science Center, Houston 77030, USA. aholian@heart.med.uth.tmc.edu
M O Uthman
T Goltsova
S D Brown
R F Hamilton
The University of Texas Health Science Center at Houston · US

Funding

Zolmitriptan challenge and human performance testingM01RR002558 · NCRR · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI SCHULTZ, STANLEY G · 1985 to 2006
$10.3M
SILICA AND ASBESTOS EFFECTS ON MACROPHAGE FUNCTIONR01ES004804 · NIEHS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI HOLIAN, ANDRIJ · 1989 to 2004
$1.1M
NCRR NIH HHS M01-RR-02558NIEHS NIH HHS ES-04804
6 · The paper itself

Abstract

The mechanism by which fibrogenic particulates induce inflammation that can progress to lung fibrosis is uncertain. The alveolar macrophage (AM) has been implicated in the inflammatory process because of its function and reported release of inflammatory mediators when isolated from fibrotic patients. It has been recently shown that fibrogenic, but not nonfibrogenic, particulates are highly potent in inducing apoptosis of human AM. In this study, we tested the hypothesis that fibrogenic particulates could shift the phenotypic ratio of human AM to a more inflammatory condition. The macrophage phenotypes were characterized by flow cytometry targeting the RFD1 and RFD7 epitopes. Results demonstrated that chrysotile and crocidolite asbestos, as well as crystalline silica, but not titanium dioxide or wollastonite, increased the RFD1+ phenotype (inducer or immune activator macrophages) and decreased the RFD1+ RFD7+ phenotype (suppressor macrophages). These results provide a mechanistic explanation that may link apoptosis (namely, suppressor macrophages) to a shift in the ratio of macrophage phenotypes that could initiate lung inflammation.

Indexed as

ApoptosisAsbestosCarcinogensCells, CulturedEpitopesFlow CytometryHumansImmunohistochemistryMacrophages, AlveolarPhenotypeSilicon DioxideAsbestosCarcinogensEpitopesSilicon Dioxide

Identifiers

PMID9400713
PMCPMC1470149
OpenAlexW1990536168

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.